Comparison of HOMA-IR, HOMA-β% and Disposition Index Between US White Men and Japanese Men in Japan: the ERA JUMP Study
Overview
Authors
Affiliations
Aims/hypothesis: At the same level of BMI, white people have less visceral adipose tissue (VAT) and are less susceptible to developing type 2 diabetes than Japanese people. No previous population-based studies have compared insulin resistance and insulin secretion between these two races in a standardised manner that accounts for VAT. We compared HOMA-IR, HOMA of beta cell function (HOMA-β%) and disposition index (DI) in US white men and Japanese men in Japan.
Methods: We conducted a population-based, cross-sectional study, comprising 298 white men and 294 Japanese men aged 40-49 years without diabetes. Insulin, glucose, VAT and other measurements were performed at the University of Pittsburgh. We used ANCOVA to compare geometric means of HOMA-IR, HOMA-β% and DI, adjusting for VAT and other covariates.
Results: White men had higher HOMA-IR, HOMA-β% and DI than Japanese men, and the difference remained significant (p < 0.01) after adjusting for VAT (geometric mean [95% CI]): 3.1 (2.9, 3.2) vs 2.5 (2.4, 2.6), 130.8 (124.6, 137.3) vs 86.7 (82.5, 91.0), and 42.4 (41.0, 44.0) vs 34.8 (33.6, 36.0), respectively. Moreover, HOMA-IR, HOMA-β% and DI were significantly higher in white men even after further adjustment for BMI, impaired fasting glucose and other risk factors.
Conclusions/interpretation: The higher VAT-adjusted DI in white men than Japanese men may partly explain lower susceptibility of white people than Japanese people to developing type 2 diabetes. The results, however, should be interpreted with caution because the assessment of insulin indices was made using fasting samples and adjustment was not made for baseline glucose tolerance. Further studies using formal methods to evaluate insulin indices are warranted.
Oh M, Cho S BMC Endocr Disord. 2025; 25(1):31.
PMID: 39910480 PMC: 11796277. DOI: 10.1186/s12902-025-01860-0.
Watanabe Y, Yamaguchi T, Sasaki A, Naitoh T, Matsubara H, Yokote K Diabetol Int. 2025; 16(1):56-64.
PMID: 39877443 PMC: 11769886. DOI: 10.1007/s13340-024-00767-w.
Clinical research progress on β-cell dysfunction in T2DM development in the Chinese population.
Chen Y, Jiang Q, Xing X, Yuan T, Li P Rev Endocr Metab Disord. 2024; 26(1):31-53.
PMID: 39382753 DOI: 10.1007/s11154-024-09914-9.
Li B, Yang Z, Liu Y, Zhou X, Wang W, Gao Z J Diabetes. 2024; 16(8):e13596.
PMID: 39136497 PMC: 11320751. DOI: 10.1111/1753-0407.13596.
Huang K, Chuang P, Yang T, Tsai Y, Li Y, Chang S Nutrients. 2024; 16(8).
PMID: 38674910 PMC: 11054352. DOI: 10.3390/nu16081220.